Division of Microbiology, Department of Pathology and Microbiology, Nihon University School of Medicine, Tokyo, Japan.
Department of Microbiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand; Center of Excellence in Emerging and Re-emerging Diarrheal Viruses, Chiang Mai University, Chiang Mai, Thailand.
J Infect Public Health. 2022 Jul;15(7):816-825. doi: 10.1016/j.jiph.2022.06.009. Epub 2022 Jun 20.
Rotavirus A (RVA) is a major cause of severe acute gastroenteritis (AGE) in infants and children worldwide. In Japan, two kinds of rotavirus vaccines have been introduced as voluntary vaccines in 2011 and 2012, respectively, and launched into the national vaccine program in October 2020.
In this study, we investigated prevalence of RVA and their molecular characterization in the stool samples collected from infants and children with AGE who visited one outpatient clinic in Japan, from July 2014 to June 2020, during voluntary vaccination with two kinds of rotavirus vaccines.
The RVA detection rates decreased from 44.7 % in 2014-2015 to 35.4 % in 2018-2019, whereas in 2019-2020 the numbers of samples collected were dramatically decreased and none of RVA was detected. During this study period, rotavirus vaccination rates in this area increased from 32.4 % to 62.2 %. Distribution of RVA VP7 (G), VP4 (P), and VP6 (I) genotypes in this area had changed year by year; the major genotype combinations were G1P[8]I1 and G1P[8]I2 in 2014-2015, G2P[4]I2 and G9P[8]I1 in 2015-2016, G1P[8]I1 and G8P[8]I2 in 2017-2018, and G8P[8]I2 in 2018-2019. Phylogenetic analysis demonstrated that VP7 nucleotide sequences of G1 were genetically diverse compared with those of other G genotypes in this study. Meanwhile, predominance of unusual G2P[8]I1, G2P[8]I2 and mixed P genotypes were observed only in 2016-2017, but did not carry on in 2017-2019. The equine-like G3 was detected only in 2016-2017.
The results revealed diversity of RVA genotypes and the genotype combinations have changed year by year in Japan, during the study period of 2016-2020.
轮状病毒 A(RVA)是全球范围内导致婴幼儿严重急性胃肠炎(AGE)的主要原因。在日本,两种轮状病毒疫苗分别于 2011 年和 2012 年作为自愿疫苗引入,并于 2020 年 10 月纳入国家疫苗计划。
本研究调查了 2014 年 7 月至 2020 年 6 月期间,在日本一家门诊就诊的 AGE 婴幼儿粪便样本中 RVA 的流行情况及其分子特征,这些婴幼儿在此期间接受了两种轮状病毒疫苗的自愿接种。
RVA 的检出率从 2014-2015 年的 44.7%降至 2018-2019 年的 35.4%,而 2019-2020 年采集的样本数量大幅减少,且未检出 RVA。在此研究期间,该地区的轮状病毒疫苗接种率从 32.4%上升至 62.2%。该地区 RVA VP7(G)、VP4(P)和 VP6(I)基因型的分布逐年变化;主要的基因型组合是 2014-2015 年的 G1P[8]I1 和 G1P[8]I2、2015-2016 年的 G2P[4]I2 和 G9P[8]I1、2017-2018 年的 G1P[8]I1 和 G8P[8]I2 以及 2018-2019 年的 G8P[8]I2。系统进化分析表明,与本研究中的其他 G 基因型相比,G1 的 VP7 核苷酸序列具有遗传多样性。同时,仅在 2016-2017 年观察到不寻常的 G2P[8]I1、G2P[8]I2 和混合 P 基因型的优势,但在 2017-2019 年没有继续存在。马源 G3 仅在 2016-2017 年被检测到。
结果表明,在 2016-2020 年的研究期间,日本 RVA 基因型具有多样性,且基因型组合逐年变化。